What is D-mannose and how does it help with cystitis?

Important note in advance: This article is for general information only and does not replace a medical diagnosis or treatment. If you suspect a urinary tract infection, especially if you have a fever, flank pain, blood in your urine, or if you are pregnant, a child, or have recurring symptoms, you should seek medical advice.

D-mannose at a glance

D-mannose is still a relatively young field in research, but is gaining increasing attention both among those affected and among some doctors as a supplementary option for urinary tract complaints.

The underlying, well-characterised mechanism: uropathogenic E. coli bacteria carry an adhesion protein called FimH on their type 1 fimbriae, which binds specifically to mannose-containing receptors on the bladder mucosa.[1][2] D-mannose can occupy this binding site, which theoretically makes it more difficult for the bacteria to adhere to the bladder wall and makes it easier for them to be flushed out with the urine.[3]

This binding mechanism is well documented in the laboratory. Whether this results in a reliable benefit in the prevention of urinary tract infections in clinical practice is – contrary to what previous studies suggested – not certain according to the current state of knowledge (see section "What does current research say?"). D-mannose should therefore be understood as a potentially supportive measure, but not as one that has been proven to be effective, and it does not replace medical assessment.

Urinary tract infections in women and men

Urinary tract infections are very common: in the USA alone, around eight million people see a doctor for this reason every year.[2]

About half of women experience a urinary tract infection at least once in their lifetime. In more than 20% of affected women, the infection recurs, and some of them experience three or more episodes per year. Men can also be affected, especially if they have an enlarged prostate.

If an infection is left untreated, it can ascend via the urethra and affect the bladder or even the kidneys. A pronounced infection can lead to fever, chills, lower abdominal pain and blood in the urine – these are warning signs that prompt medical attention is required.

In around 90% of cases, the infection is caused by the bacterium Escherichia coli (E. coli), which enters the bladder via the urethra. Women are affected more frequently than men due to the anatomical proximity of the urethral opening and anus.

If E. coli enters the urinary tract, it adheres to the bladder mucosa with finger-like appendages and can cause irritation and inflammation – with the typical symptoms such as frequent urination, burning and discomfort.

Antibiotics are still the treatment most commonly prescribed by doctors. A well-known disadvantage: they do not act selectively only against the harmful bacteria, but also affect beneficial bacteria in the intestine, vagina and urinary tract. This can temporarily weaken the natural defences and increase the risk of secondary infections such as vaginal thrush or renewed bladder infections.

After antibiotic treatment, it can therefore be useful to support the development of the intestinal flora with a probiotic – this process can take several months. It is best to discuss such measures with your doctor or pharmacist.

D-mannose as a natural supplement

In addition to antibiotics, there are natural approaches that are being discussed as a supplement – not a replacement – to support urinary tract health. Cranberry juice is one of the best known. Since sugar is added to many commercially available juices, drinking large quantities is not an ideal solution, because sugar can promote the growth of precisely those bacteria that you actually want to fight. Cranberry capsules are often more practical in this case.

D-mannose is another much-discussed natural option. Studies suggest that it has binding sites similar to those on the inner wall of the urinary bladder, where bacteria such as E. coli normally attach themselves. A higher concentration of D-mannose in the urine could therefore lead to bacteria preferentially binding to the D-mannose molecules instead of to the bladder wall, and thus being more easily excreted.

D-mannose is a simple sugar that is structurally related to glucose and occurs naturally in small amounts in fruits such as peaches, apples, oranges, cranberries and blueberries. The body can also produce D-mannose itself. In animal studies, a dose-dependent reduction in the number of bacteria was observed, in some cases within just one day.[3] Such animal study results cannot be transferred to humans without reservation, but they do provide an indication of the possible mechanism of action.

D-mannose is hardly metabolised in the body and therefore has practically no effect on blood sugar levels – one reason why it is sometimes discussed as an option for people with diabetes. As with any dietary supplement, if you have any existing medical conditions or are taking any medication, discuss its use with your doctor or pharmacist in advance.

How D-mannose could work

E. coli bacteria have tiny, finger-like appendages, called fimbriae, with which they can attach themselves to the inner wall of the bladder and even ascend via the ureters to the kidneys. These appendages consist, among other things, of a glycoprotein called lectin, which is responsible for their ability to adhere.[4]

Mannose also occurs naturally in the body and covers the inner wall of the urinary organs. If the body does not produce enough of its own mannose, the natural defence mechanism can be weakened, making it easier for bacteria to attach to the bladder wall.

If you take D-mannose as a dietary supplement, it passes through the kidneys into the urine. Since D-mannose apparently binds even more strongly to the lectins of E. coli than the body's own cell receptors, the bacteria may detach from the bladder wall and instead bind to the D-mannose molecules, making them easier to excrete in the urine.[5]

In older advisory texts, a possible connection with the body's own Tamm-Horsfall protein, which also plays a role in the defence against urinary tract infections, is sometimes additionally discussed. We were unable to verify a reliable, up-to-date primary source for this specific link to D-mannose – this point should therefore either be supported by a verifiable study or removed from the article, rather than being presented as an established fact.

D-mannose seems to be particularly relevant for urinary tract infections caused by E. coli – this is estimated to affect more than 90% of cases. If there is uncertainty, the doctor can order a urine culture to determine the causative pathogen.

Dosage and administration

The following information provides general guidance values as they are often used in practice. It does not replace individual medical or pharmaceutical advice, especially not for children, during pregnancy/breastfeeding or in the case of existing pre-existing conditions.

• For acute symptoms: approx. 1 teaspoon (approx. 2 g) for adults, ½ to 1 teaspoon for children, dissolved in a glass of water; the intake can be repeated every two to three hours and continued for two to three days after the symptoms have subsided.
• For longer-term support: usually 1 teaspoon daily, dissolved in water.
• In connection with sexual intercourse: sometimes it is taken about an hour beforehand and again immediately afterwards.

In addition, follow the recommended intake on the product packaging. If the symptoms do not improve after 2–3 days, or if you experience fever, back pain or pain in the flank, consult a doctor promptly – these can be indications of an ascending or kidney infection, which can become dangerous if left untreated.

Possible side effects and precautions

Based on previous experience and the available studies, D-mannose is considered to be well tolerated, and serious side effects have rarely been reported to date. However, with very high amounts, mild gastrointestinal symptoms such as flatulence or loose stools can occasionally occur.

As with any dietary supplement, it is not possible to guarantee that there will be absolutely no side effects. People with pre-existing conditions, pregnant women, breastfeeding women and parents of children should discuss taking the product with a doctor or pharmacist in advance.

D-mannose can usually be taken in addition to an existing antibiotic therapy without impairing its effect. Nevertheless, discuss any combination with your doctor, especially if you are taking other medications.

D-mannose or cranberry juice – which makes more sense?

Cranberry juice has also long been known for its possible supportive effect on urinary tract health. Cranberries themselves contain small amounts of D-mannose, which can help reduce the adhesion of E. coli to the bladder wall.

However, cranberries contain only small amounts of D-mannose compared to pure D-mannose powder. Cranberry juice and extract also provide proanthocyanidins (PACs), which act via a different mechanism: they make it more difficult for P-fimbria-carrying E. coli strains in particular to adhere to the bladder mucosa.[8][9] D-mannose and proanthocyanidins could usefully complement each other in combination, as they target different bacterial strains – but reliable clinical comparative data in humans is still limited. An analysis published in 2024 also indicated that, in direct comparisons, cranberry preparations sometimes showed more consistent effects than D-mannose.[10]

A practical problem with cranberry juice: in order to consume a relevant amount, one would have to drink larger quantities regularly. Many commercially available juices contain added sugar, which can promote the growth of E. coli; unsweetened versions taste too sour for many people. Cranberry capsules are often a more practical alternative here.

Concentrated D-mannose powder delivers a significantly higher dose of the active ingredient per serving than cranberry juice. Reliable, direct comparative studies on the relative potency of both approaches in humans have so far been limited; however, initial reports of experiences and the available studies indicate that many users notice an improvement within a few days.

What does current research say?

The research on D-mannose is more inconsistent than older sources often convey – this should be presented transparently in a reputable guide.

Older study (2014): In a widely cited study involving 308 women with recurrent urinary tract infections, the participants received either 2 g of D-mannose, a low-dose antibiotic (nitrofurantoin) or no prophylaxis daily for six months. Both active ingredient groups had fewer recurrent infections than the group without prophylaxis, and side effects occurred less frequently in the D-mannose group than in the antibiotic group.[4] However, this study did not have a placebo arm – that is, a possible placebo effect cannot be ruled out, which puts the results into perspective.

More recent, placebo-controlled study (2024): A significantly larger, double-blind, placebo-controlled randomised study of 598 women in British primary care, published in JAMA Internal Medicine, came to a different conclusion: D-mannose taken daily for six months did not significantly reduce the risk of a new, medically treated urinary tract infection compared to placebo (51.0% vs 55.7% of participants had a new infection). There were also no significant differences in the duration of symptoms, the time until the next consultation, or the use of antibiotics. The study authors concluded that daily D-mannose should not be recommended for the prevention of recurrent urinary tract infections.[5]

Current meta-analyses (2025): Two independent systematic reviews from 2025, which summarise several randomised trials, come to a similar conclusion: in the overall view of the available randomised trials, D-mannose did not significantly reduce the risk of a recurrent urinary tract infection compared to placebo or no treatment.[6][7]

What this means in practice: The underlying binding mechanism is plausible and well studied in the laboratory, but the best clinical evidence currently available does not support the equivalence with antibiotics often claimed in older marketing texts . Some users nevertheless report a subjective improvement; whether this is due to D-mannose itself, the natural course of mild infections or a placebo effect cannot be reliably determined in individual cases.

An additional precautionary measure expressed in connection with the 2024 study: since D-mannose is a sugar, it was suggested in the expert discussion that people with diabetes or insulin resistance should be as careful as possible and clarify its intake with a doctor.[5]

Important: D-mannose is not an approved medicinal product and is not a substitute for antibiotic therapy prescribed by a doctor if this is medically necessary. Whether antibiotics are required in an individual case should always be clarified by a doctor – especially in the event of fever, severe pain, pregnancy or suspected kidney involvement.

Sources

1. Schaeffer AJ. Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection. J Urol. 2002. https://pubmed.ncbi.nlm.nih.gov/12010488/ 
2. Scribano D, et al. Considerations on D-mannose Mechanism of Action and Consequent Classification of Marketed Healthcare Products. Front Pharmacol. 2021. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.636377/full 
3. Systematic review of the effect of D-mannose with or without other agents on urinary tract infections. Biomed Rep. 2022. https://www.spandidos-publications.com/10.3892/br.2022.1552 
4. Kranjčec B, Papeš D, Altarac S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomised clinical trial. World J Urol. 2014;32(1):79–84. https://pubmed.ncbi.nlm.nih.gov/23633128/ 
5. Hayward G, Mort S, Hay AD, et al. D-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women: A Randomised Clinical Trial. JAMA Intern Med. 2024;184(6):619–628. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11002776/ (Full text also via https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2817488)
6. Vargas CEF, et al. Efficacy of D-mannose as prophylaxis of recurrent urinary tract infection: a systematic review and meta-analysis of RCTs. 2025. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12471090/ 
7. Murali Krishna M, Joseph M, Pereira V, et al. D-Mannose for prevention of recurrent urinary tract infection in adult women: an updated systematic review and meta-analysis of RCTs. 2025. https://journals.sagepub.com/doi/10.1177/17571774251394869 
8. Di Martino P, et al. Anti-Adhesion Activity of A2-type Proanthocyanidins (a Cranberry Major Component) on Uropathogenic E. coli and P. mirabilis Strains. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790394/ 
9. Cranberry-derived bioactives for the prevention and treatment of urinary tract infections: antimicrobial mechanisms and global research trends. Front Nutr. 2025. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2025.1502720/full 
10. Cranberry outperforms D-mannose in urinary tract health trial. NutraIngredients, 10 June 2024 (Classification of the JAMA 2024 study in comparison to cranberry research). https://www.nutraingredients.com/Article/2024/06/10/cranberry-outperforms-d-mannose-in-urinary-tract-health-trial/ 

This article is for general information purposes only and does not constitute medical advice. It is not a substitute for seeing a doctor. In the event of persistent, recurring or worsening symptoms, fever, blood in the urine, flank pain, during pregnancy, in children or with existing pre-existing conditions, please contact a medical professional.